Sources
Loading...
Additional media
Loading...

The biotech sector has seen a significant rebound, with stocks surging by 50% since October lows. Investors are returning to biotech after a challenging period, with industry experts optimistic about the sector's future growth potential.
Biotech’s Rally Is Just Getting Started https://t.co/xHwWxmTvYW
Investing in biotech stocks used to be seen as risky enterprise offset by the prospect of spectacular growth. But after a COVID-provoked investment peak, biotech has become part of the mainstream, according to our latest Data Page https://t.co/E2Rfkg6gih https://t.co/akzWyKGIhO
Investors flock back to biotech after a long, cold spell https://t.co/sDsyBsZ5Je via @WSJ


